Porvair PLC
28 August 2026
28 August 2026
Porvair plc
("Porvair" or the "Group" or the "Company")
Admission to Trading
In accordance with PRM 1.6.4R, the Company announces that 105,218 ordinary shares of 2 pence each have been issued and admitted to trading as set out in the table below.
|
1 |
Details of the issuer |
|
|
a) |
Name of issuer |
Porvair plc |
|
b) |
Legal entity identifier (LEI) of issuer |
213800ECKHS8LAQO3C45 |
|
2 |
Details of the transferable securities admitted to trading |
|
|
a) |
Regulated market |
London Stock Exchange (XLON); Main Market |
|
b) |
Name, type and ISIN of the securities |
Ordinary shares of 2 pence each ISIN: GB0006963689 |
|
c) |
Number of further securities admitted to trading covered by this notification |
105,218 |
|
d) |
Total number of securities admitted to trading following further issuance |
46,609,136 |
|
e) |
Fungibility |
Fully fungible with existing ordinary shares |
|
3 |
Issue and admission details |
|
|
a) |
Date of issuance and admission to trading |
Issued on various dates between 30 June 2026 and 26 August 2026. All issued shares covered by this notification were admitted to trading under an existing block admissions for the Company's SAYE Scheme. |
|
b) |
Prospectus information |
N/A |
For more information, contact:
|
Porvair plc |
+44 (0)1553 765 500 |
|
|
Andrew Douglass, Group Company Secretary |
||
Notes to Editors
Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.